These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 23899930)

  • 21. Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry.
    Shah B; Hernandez AF; Liang L; Al-Khatib SM; Yancy CW; Fonarow GC; Peterson ED;
    J Am Coll Cardiol; 2009 Feb; 53(5):416-22. PubMed ID: 19179199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.
    Fonarow GC; Abraham WT; Albert NM; Gattis WA; Gheorghiade M; Greenberg B; O'Connor CM; Yancy CW; Young J
    Am Heart J; 2004 Jul; 148(1):43-51. PubMed ID: 15215791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship Between Enrolling Country Income Level and Patient Profile, Protocol Completion, and Trial End Points.
    Greene SJ; Hernandez AF; Sun JL; Butler J; Armstrong PW; Ezekowitz JA; Zannad F; Ferreira JP; Coles A; Metra M; Voors AA; Califf RM; O'Connor CM; Mentz RJ
    Circ Cardiovasc Qual Outcomes; 2018 Oct; 11(10):e004783. PubMed ID: 30354576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of Patient Goals of Care on Performance Measures in Patients Hospitalized for Heart Failure: An Analysis of the Enhanced Feedback For Effective Cardiac Treatment (EFFECT) Registry.
    McAlister FA; Wang J; Donovan L; Lee DS; Armstrong PW; Tu JV
    Circ Heart Fail; 2015 May; 8(3):481-8. PubMed ID: 25669939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of patient-specific quality-of-care report cards on guideline adherence in heart failure.
    Matthews JC; Johnson ML; Koelling TM
    Am Heart J; 2007 Dec; 154(6):1174-83. PubMed ID: 18035092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management strategies to meet the core heart failure measures for acute decompensated heart failure: a nursing perspective.
    Gardetto NJ; Carroll KC
    Crit Care Nurs Q; 2007; 30(4):307-20. PubMed ID: 17873567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guideline adherence after ST-segment elevation versus non-ST segment elevation myocardial infarction.
    Somma KA; Bhatt DL; Fonarow GC; Cannon CP; Cox M; Laskey W; Peacock WF; Hernandez AF; Peterson ED; Schwamm L; Saxon LA
    Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):654-61. PubMed ID: 22949493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment.
    Munger MA; Ng TM; Van Tassell BW
    Pharmacotherapy; 2007 May; 27(5):619-25. PubMed ID: 17461695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models.
    Khazanie P; Heizer GM; Hasselblad V; Armstrong PW; Califf RM; Ezekowitz J; Dickstein K; Levy WC; McMurray JJ; Metra M; Tang WH; Teerlink JR; Voors AA; O'Connor CM; Hernandez AF; Starling R
    Am Heart J; 2015 Aug; 170(2):290-7. PubMed ID: 26299226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure.
    Tang WH; Wu Y; Grodin JL; Hsu AP; Hernandez AF; Butler J; Metra M; Voors AA; Felker GM; Troughton RW; Mills RM; McMurray JJ; Armstrong PW; O'Connor CM; Starling RC
    JACC Heart Fail; 2016 Jan; 4(1):68-77. PubMed ID: 26656144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial.
    Ambrosy AP; Cerbin LP; Armstrong PW; Butler J; Coles A; DeVore AD; Dunlap ME; Ezekowitz JA; Felker GM; Fudim M; Greene SJ; Hernandez AF; O'Connor CM; Schulte P; Starling RC; Teerlink JR; Voors AA; Mentz RJ
    JACC Heart Fail; 2017 Jan; 5(1):1-13. PubMed ID: 28034373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment.
    Miller AH; Nazeer S; Pepe P; Estes B; Gorman A; Yancy CW
    Ann Emerg Med; 2008 May; 51(5):571-8. PubMed ID: 18304693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF).
    Fonarow GC; Albert NM; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; McBride ML; Inge PJ; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
    Circulation; 2010 Aug; 122(6):585-96. PubMed ID: 20660805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left ventricular ejection fraction assessment among patients with acute myocardial infarction and its association with hospital quality of care and evidence-based therapy use.
    Miller AL; Dib C; Li L; Chen AY; Amsterdam E; Funk M; Saucedo JF; Wang TY
    Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):662-71. PubMed ID: 22949495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure: insights from the ASCEND-HF Trial.
    Toma M; Ezekowitz JA; Bakal JA; O'Connor CM; Hernandez AF; Sardar MR; Zolty R; Massie BM; Swedberg K; Armstrong PW; Starling RC
    Eur J Heart Fail; 2014 Mar; 16(3):334-41. PubMed ID: 24464687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nesiritide for the treatment of decompensated heart failure.
    Wylie JV; Tsao L
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):803-13. PubMed ID: 15500426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medication Initiation Burden Required to Comply With Heart Failure Guideline Recommendations and Hospital Quality Measures.
    Allen LA; Fonarow GC; Liang L; Schulte PJ; Masoudi FA; Rumsfeld JS; Ho PM; Eapen ZJ; Hernandez AF; Heidenreich PA; Bhatt DL; Peterson ED; Krumholz HM;
    Circulation; 2015 Oct; 132(14):1347-53. PubMed ID: 26316616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Observation unit treatment of heart failure with nesiritide: results from the proaction trial.
    Peacock WF; Holland R; Gyarmathy R; Dunbar L; Klapholz M; Horton DP; de Lissovoy G; Emerman CL
    J Emerg Med; 2005 Oct; 29(3):243-52. PubMed ID: 16183441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF).
    Fonarow GC; Abraham WT; Albert NM; Gattis Stough W; Gheorghiade M; Greenberg BH; O'Connor CM; Pieper K; Sun JL; Yancy CW; Young JB;
    Arch Intern Med; 2007 Jul; 167(14):1493-502. PubMed ID: 17646603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.